Treatment of Chronic Heart Failure With β-Adrenergic Receptor Antagonists
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of Chronic Heart Failure With β-Adrenergic Receptor Antagonists
Authors
Keywords
-
Journal
CIRCULATION RESEARCH
Volume 109, Issue 10, Pages 1176-1194
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2011-10-28
DOI
10.1161/circresaha.111.245092
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- β-Adrenergic Receptor Stimulation and Activation of Protein Kinase A Protect Against α1-Adrenergic–Mediated Phosphorylation of Protein Kinase D and Histone Deacetylase 5
- (2011) Carmen C. Sucharov et al. JOURNAL OF CARDIAC FAILURE
- Influence of Global Region on Outcomes in Heart Failure Beta-Blocker Trials
- (2011) Christopher M. O'Connor et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- KMUP-1 attenuates isoprenaline-induced cardiac hypertrophy in rats through NO/cGMP/PKG and ERK1/2/calcineurin A pathways
- (2010) Jwu-Lai Yeh et al. BRITISH JOURNAL OF PHARMACOLOGY
- Small Molecule Disruption of Gβγ Signaling Inhibits the Progression of Heart Failure
- (2010) Liam M. Casey et al. CIRCULATION RESEARCH
- HFSA 2010 Comprehensive Heart Failure Practice Guideline
- (2010) Heart Failure Society of America JOURNAL OF CARDIAC FAILURE
- IMPACT OF BASELINE VOLUME STATUS AND LVEF ON ALL-CAUSE MORTALITY IN THE BEST TRIAL
- (2010) Inderjit S. Anand et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- An α 2C -Adrenergic Receptor Polymorphism Alters the Norepinephrine-Lowering Effects and Therapeutic Response of the β-Blocker Bucindolol in Chronic Heart Failure
- (2009) Michael R. Bristow et al. Circulation-Heart Failure
- Increased Phosphorylation-Dependent Nuclear Export of Class II Histone Deacetylases in Failing Human Heart
- (2009) Mihail B. Calalb et al. CTS-Clinical and Translational Science
- Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials
- (2009) M. Metra et al. EUROPEAN HEART JOURNAL
- Decreased beta-adrenergic responsiveness following hypertrophy occurs only in cardiomyocytes that also re-express beta-myosin heavy chain
- (2009) Kumar Pandya et al. EUROPEAN JOURNAL OF HEART FAILURE
- CaMKII and a failing strategy for growth in heart
- (2009) Mark E. Anderson JOURNAL OF CLINICAL INVESTIGATION
- Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the β3-adrenoreceptor
- (2009) An L. Moens et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- β-Adrenergic receptor signaling in the heart: Role of CaMKII
- (2009) Michael Grimm et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Myocardial Adeno-Associated Virus Serotype 6–βARKct Gene Therapy Improves Cardiac Function and Normalizes the Neurohormonal Axis in Chronic Heart Failure
- (2008) Giuseppe Rengo et al. CIRCULATION
- Ca 2+ /Calmodulin-Dependent Protein Kinase IIδ and Protein Kinase D Overexpression Reinforce the Histone Deacetylase 5 Redistribution in Heart Failure
- (2008) Julie Bossuyt et al. CIRCULATION RESEARCH
- Effect of the b 3 -Receptor Antagonist SR59230A on Bucindolol-Induced Release of Nitric Oxide and Peroxynitrite from Human Endothelium
- (2008) R. Preston Mason et al. JOURNAL OF CARDIAC FAILURE
- Additive Effects of β 1 389 Arg/Gly α 2c 322–325 Wt/Del Genotype Combinations on Adjudicated Hospitalizations and Death in the Beta-Blocker Evaluation of Survival Trial (BEST)
- (2008) O'Connor C. et al. JOURNAL OF CARDIAC FAILURE
- Cardioprotective and Survival Benefits of Long-Term Combined Therapy with 2 Adrenoreceptor (AR) Agonist and 1 AR Blocker in Dilated Cardiomyopathy Postmyocardial Infarction
- (2008) I. Ahmet et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Lack of Association Between Adrenergic Receptor Genotypes and Survival in Heart Failure Patients Treated With Carvedilol or Metoprolol
- (2008) Amy J. Sehnert et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- -Blockers alprenolol and carvedilol stimulate -arrestin-mediated EGFR transactivation
- (2008) I.-M. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now